ArticleScientific reports2026
The ROBOKOP v1.0 knowledge graph system for exploring relationships between biomedical entities.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
ROBOKOP (Reasoning Over Biomedical Objects linked in Knowledge Oriented Pathways) is an open-source, modular, biomedical, knowledge graph (KG)-based system comprised of several key components: the ROBOKOP KG; a user interface (UI); and a variety of supporting resources, including tools and services to support deep exploration of the ROBOKOP KG and each of its underlying knowledge sources. A custom software pipeline termed Operational Routine for the Ingest and Output of Networks (ORION) standardizes, integrates, and harmonizes ROBOKOP's knowledge sources as interoperable KGs by leveraging the community-developed Biolink Model's universal KG schema and upper-level biomedical ontology. A ROBOKOP Graphs interface exposes the ROBOKOP KG and the other interoperable KGs, thus supporting access independent of the UI. All components of ROBOKOP are publicly accessible. Herein, we describe the v1.0 major release of ROBOKOP and highlight its features and functionalities in several application use cases, including a validation use case on asthma gene targets and two user-provided exploratory use cases on cardiotoxicity related to exposure to brominated flame retardants and diabetes mellitus related to exposure to agricultural pesticides.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.